Literature DB >> 15607941

Schwann cell overexpression of the GPR7 receptor in inflammatory and painful neuropathies.

Paola F Zaratin1, Angelo Quattrini, Stefano C Previtali, Giancarlo Comi, Guillaume Hervieu, Mark A Scheideler.   

Abstract

The human 7-transmembrane receptor GPR7 has sequence similarity to opioid and somatostatin receptors, and can be activated by the recently discovered neuropeptides NPB and NPW. This receptor is highly expressed in the nervous system, with suggested roles in neuroendocrine events and pain signaling. In this study, we investigated whether the GPR7 receptor is expressed in the peripheral nervous system under normal and pathological conditions. A low level of GPR7 receptor was observed in myelin-forming Schwann cells in both normal human and rat nerve, and in primary rat Schwann cell cultures. Peripheral nerve samples taken from patients exhibiting inflammatory/immune-mediated neuropathies showed a dramatic increase of GPR7 receptor expression restricted to myelin-forming Schwann cells. Complementary animal models of immune-inflammatory and ligation-induced nerve injury and neuropathic pain similarly exhibited an increased myelin-associated expression of GPR7 receptor. These results suggest a relationship between the pathogenesis of inflammatory/immune-mediated neuropathies, GPR7 receptor expression, and pain transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607941     DOI: 10.1016/j.mcn.2004.08.010

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  9 in total

Review 1.  Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering.

Authors:  Brad R Green; Misty Smith; Karen L White; H Steve White; Grzegorz Bulaj
Journal:  ACS Chem Neurosci       Date:  2010-11-18       Impact factor: 4.418

Review 2.  Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system.

Authors:  Gurminder Singh; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

3.  Differential Gene Expression in Cord Blood of Infants Diagnosed with Cerebral Palsy: A Pilot Analysis of the Beneficial Effects of Antenatal Magnesium Cohort.

Authors:  Maria L V Dizon; Raye-Ann O deRegnier; Steven J Weiner; Michael W Varner; Dwight J Rouse; Maged M Costantine; Ronald J Wapner; John M Thorp; Sean C Blackwell; Nina K Ayala; Antonio F Saad; Steve N Caritis
Journal:  Dev Neurosci       Date:  2022-06-15       Impact factor: 3.421

4.  Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7).

Authors:  Mariangela Urbano; Miguel Guerrero; Jian Zhao; Subash Velaparthi; S Adrian Saldanha; Peter Chase; Zhiwei Wang; Olivier Civelli; Peter Hodder; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-10-02       Impact factor: 2.823

5.  SAR analysis of novel non-peptidic NPBWR1 (GPR7) antagonists.

Authors:  Miguel Guerrero; Mariangela Urbano; Marie-Therese Schaeffer; Steven Brown; Hugh Rosen; Edward Roberts
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

6.  Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability.

Authors:  Thuy Nguyen; Ann M Decker; Rodney W Snyder; Emma C Tonetti; Thomas F Gamage; Yanan Zhang
Journal:  Eur J Med Chem       Date:  2022-01-21       Impact factor: 6.514

7.  NPBWR1 and NPBWR2: Implications in Energy Homeostasis, Pain, and Emotion.

Authors:  Takeshi Sakurai
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-18       Impact factor: 5.555

Review 8.  Distribution and Function of Neuropeptides W/B Signaling System.

Authors:  Magdalena Chottova Dvorakova
Journal:  Front Physiol       Date:  2018-07-24       Impact factor: 4.566

9.  Neuropeptide W regulates proliferation and differentiation of ATDC5: Possible involvement of GPR7 activation, PKA and PKC-dependent signalling cascades.

Authors:  RiKang Wang; Chaojun Zheng; Wenyu Jiang; Xinshu Xie; Rifang Liao; Guangqian Zhou
Journal:  J Cell Mol Med       Date:  2019-01-04       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.